Ocumetics Technology Corp. (OTCFF)

OTCMKTS · Delayed Price · Currency is USD
0.2970
0.00 (0.00%)
Jul 10, 2025, 4:00 PM EDT
38.14%
Market Cap 34.14M
Revenue (ttm) n/a
Net Income (ttm) -2.28M
Shares Out n/a
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 45,000
Average Volume 25,484
Open 0.2970
Previous Close 0.2970
Day's Range 0.2970 - 0.2970
52-Week Range 0.1872 - 0.3555
Beta -0.72
RSI 63.03
Earnings Date Aug 28, 2025

About Ocumetics Technology

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. The company develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed changed its name to Ocumetics Technology Corp. in August 2021. Ocumetics Technology Corp. was founded in 2012 and is headquartered in Calgary, Canada. [Read more]

Sector Healthcare
Founded 2012
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol OTCFF
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

Ocumetics Completes Staff Training for First-In-Human Clinical Study of Accommodating Intraocular Lens

Calgary, Alberta – TheNewswire - July 9, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is please...

2 days ago - TheNewswire

Ocumetics Completes Virtual Site Initiation for First-In-Human Clinical Study of Accommodating Intraocular Lens

Calgary, Alberta – TheNewswire - June 26, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleas...

15 days ago - TheNewswire

First-In-Human Study of Accommodating Intraocular Lens Set to Begin June 26, 2025

Calgary, Alberta – TheNewswire - June 24, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleas...

17 days ago - TheNewswire

Ocumetics Announces Private Placement

Calgary, Alberta – TheNewswire - June 4, 2025 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a privat...

5 weeks ago - TheNewswire

Ocumetics Targets June 26, 2025 for Commencement of its First in Human Study

Calgary, Alberta - TheNewswire - – June 3, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is plea...

5 weeks ago - TheNewswire

Ocumetics Announces Mexico City as Site for its First in Human Study

Calgary, Alberta – TheNewswire - June 2, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is please...

5 weeks ago - TheNewswire

Ocumetics Clinical Study Protocol Submission and Site Initiation on Schedule for Summer 2025

Calgary, Alberta – TheNewswire - May 22, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is please...

7 weeks ago - TheNewswire

Ocumetics Completes Manufacturing of Lenses to be used in First-in-Human Study

Calgary, Alberta – TheNewswire - May 14, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is please...

2 months ago - TheNewswire

Ocumetics Announces Lens Design Freeze for First-in-Human Study

Calgary, Alberta – TheNewswire - May 12 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased ...

2 months ago - TheNewswire

Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials

Calgary, Alberta – TheNewswire - May 8, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased ...

2 months ago - TheNewswire

Ocumetics Announces Corporate Changes

Calgary, Alberta – TheNewswire - May 1, 2025 - Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) (the “ Corporation ” or “ Ocumetics ”) announces that Mr. Dayton Marks has resigned as ...

2 months ago - TheNewswire

Ocumetics Announces Completion of Major Milestones First-In-Human Surgery Planned for Summer 2025

Calgary, Alberta – TheNewswire - April 22, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is plea...

2 months ago - TheNewswire

Ocumetics Engages Independent Trading Group as Market Maker

Calgary, Alberta – TheNewswire - March 24, 2025 – Ocumetics Technology Corp. (“ Ocumetics ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce ...

3 months ago - TheNewswire

Ocumetics Announces Appointment of Michael L. Edwards to Board of Directors

Calgary, Alberta – TheNewswire - March 11, 2025.   Ocumetics Technology Corp. (“ Ocumetics” or the “Corporation”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, ...

4 months ago - TheNewswire